You are here
posted on January 9, 2015
In December, Vice President for Research Brian Herman presented the annual state of University research report to the University Regents. The U’s research enterprise is strong, with growth in nearly all performance measures during FY14.
You can see VP Herman's summary of the report on the OVPR Inquiry blog. The article also includes a link to the complete report.
posted on January 6, 2015
The U’s Center for Sustainable Polymers (CSP) was featured in a video recently on the National Science Foundation’s Science Nation website. Two MSI Principal Investigators from the Center are featured in the video: Professor Marc Hillmyer (CSP Director; Chemistry) and Professor Chris Cramer (MSI Fellow; Chemistry). Researchers at the CSP are developing methods of using sustainable materials, rather than petroleum, to create plastics. Both Professors Hillmyer and Cramer use MSI to support their research in polymer chemistry.
Watch the video at the Science Nation website.
posted on January 5, 2015
On Wednesday, January 7, from 04:00 - 15:00, MSI staff will perform scheduled maintenance and upgrades to the network and various systems.
During this maintenance period, we will be performing the following updates:
• Panasas server software upgrade to 6.0.2
• Itasca system software upgrades and moab/torque upgrades
• Cascade system software upgrades and moab/torque upgrades
• Expressionist volume migration
• Galaxy volume migration/resizing
The Panasas update will result in a system-wide stall during the update process. Running jobs should simply pause until the Panasas systems return to service.
Systems status is always available on our Status page.
If you have any questions, please email email@example.com.
posted on December 16, 2014
Two MSI Principal Investigators, Associate Professor Reuben Harris (Biochemistry, Molecular Biology, and Biophysics) and Assistant Professor Daniel Harki (Medicinal Chemistry), have founded a start-up company that will create drug therapies for cancer treatment. ApoGen Biotechnologies, Inc. is developing a new class of drugs based on blocking the activity of the protein APOBEC, which is found in many cancer tumors. Both Professors Harris and Harki use MSI to support their research into APOBEC-family proteins.
An article about ApoGen Biotechnologies appeared recently on the OVPR’s Inquiry blog.
posted on December 10, 2014
Principal Investigator Dan Knights, an assistant professor in the Department of Computer Science and Engineering (College of Science and Engineering), was featured recently in an article that appeared in the [St. Paul, Minnesota] Pioneer Press. The article discusses his research into the human microbiome, for which he uses MSI. You can read the article on the TwinCities.com website.